Skip to main content
UniHealth

Doctor search

Rachel Knight Hopper, MD

Pediatric Medicine · Palo Alto

NPI 1114193133

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
1
1 carrier
Office
1

Offices

1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group

Looking this up.

Plans that list them

1 plan · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hopper’s office at (650) 498-7200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026

California Medical Board record

Licence A110573 · Current

Licensed to practise in California · since 2010 · expires 2027-08-31 · University of Michigan Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Medicaid work

$24,478 in 2024

Medicaid paid $24,478 for 121 billed services this clinician did in 2024, up to 22 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)121$24,478
Medicaid work by year
2024121122$24,478
2023157120$22,077
2022116124$17,874
2021209217$19,325
2020103216$8,696
2019161216$13,186
201898117$6,403
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)157$22,077

2022

Largest Medicaid services in 2022
Long return visit (40+ min)116$17,874

2021

Largest Medicaid services in 2021
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES147$10,348
Long return visit (40+ min)62$8,978

2020

Largest Medicaid services in 2020
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES73$4,774
Long return visit (40+ min)30$3,921

2019

Largest Medicaid services in 2019
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES118$7,638
Long return visit (40+ min)43$5,548

2018

Largest Medicaid services in 2018
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES98$6,403

Money from drug and device companies

$19 in 2025

Industry payments by year
202513None$19
202412None$42

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Merck Sharp & DohmeNone$19
3 payments
  • Meals · 2025-10-16 · $5
  • Meals · 2025-07-18 · $8
  • Meals · 2025-01-29 · $6
See all 3 published payments
Every published payment
Merck Sharp & DohmeMeals · 2025-10-16None$5
Merck Sharp & DohmeMeals · 2025-07-18None$8
Merck Sharp & DohmeMeals · 2025-01-29None$6
See earlier years (2024)

2024: $42

Payments by company in 2024
Merck Sharp & DohmeNone$42
2 payments
  • Meals · 2024-10-15 · $7
  • Meals · 2024-06-29 · $35

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Merck Sharp & Dohme LLC · A Phase 2 Open-Label Study To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept Mk-7962 in Children From 1 To Less Than 18 Years of Age With Pah on Standard of Care · 2024Their institution$87,321
Merck Sharp & Dohme LLC · A Phase 2 Open-Label Study To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept Mk-7962 in Children From 1 To Less Than 18 Years of Age With Pah on Standard of Care · 2025Their institution$53,018
Merck Sharp & Dohme LLC · A Phase 2 Open-Label Study To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept Mk-7962 in Children From 1 To Less Than 18 Years of Age With Pah on Standard of Care · 2022Their institution$39,629
Merck Sharp & Dohme LLC · A Phase 2 Open-Label Study To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept Mk-7962 in Children From 1 To Less Than 18 Years of Age With Pah on Standard of Care · 2023Their institution$35,399

Professional record

NPI
1114193133
Licence
CA A110573, PA MD452602California A110573: Current · expires 2027-08-31
Trained
University of Michigan Medical School, 2007
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 2080P0202X (2080P0202X); Pediatrics (208000000X)
Mailing address
725 Welch Rd, Palo Alto, CA, 94304
NPI first listed
2008-04-30
NPI last updated
2024-04-11
NPI record certified
2024-04-11

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 725 Welch Rd Ste 181, Palo Alto, CA, 94304